194 related articles for article (PubMed ID: 16740031)
1. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma.
Xiao GQ; Burstein DE; Miller LK; Unger PD
Arch Pathol Lab Med; 2006 Jun; 130(6):805-10. PubMed ID: 16740031
[TBL] [Abstract][Full Text] [Related]
2. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma.
Skinnider BF; Oliva E; Young RH; Amin MB
Am J Surg Pathol; 2004 Jun; 28(6):701-5. PubMed ID: 15166661
[TBL] [Abstract][Full Text] [Related]
3. S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma.
Cossu-Rocca P; Contini M; Brunelli M; Festa A; Pili F; Gobbo S; Eccher A; Mura A; Massarelli G; Martignoni G
Am J Surg Pathol; 2009 Jul; 33(7):1031-6. PubMed ID: 19384190
[TBL] [Abstract][Full Text] [Related]
4. Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma.
Gupta A; Wang HL; Policarpio-Nicolas ML; Tretiakova MS; Papavero V; Pins MR; Jiang Z; Humphrey PA; Cheng L; Yang XJ
Am J Surg Pathol; 2004 Sep; 28(9):1224-9. PubMed ID: 15316323
[TBL] [Abstract][Full Text] [Related]
5. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma.
Hansel DE; Nadasdy T; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1231-7. PubMed ID: 17667548
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic adenoma of the urinary tract: a review.
Alexiev BA; LeVea CM
Int J Surg Pathol; 2012 Apr; 20(2):123-31. PubMed ID: 22415059
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3.
McDaniel AS; Chinnaiyan AM; Siddiqui J; McKenney JK; Mehra R
Am J Surg Pathol; 2014 Dec; 38(12):1664-71. PubMed ID: 24921643
[TBL] [Abstract][Full Text] [Related]
8. Nephrogenic Adenoma of the Prostatic Urethra Mimicking Prostatic and Bladder Carcinomas.
Beeter MC; Fazili T; Yeh YA
Cureus; 2023 Mar; 15(3):e35998. PubMed ID: 37041930
[TBL] [Abstract][Full Text] [Related]
9. Clear cell adenocarcinoma of urinary bladder and urethra: another urinary tract lesion immunoreactive for P504S.
Sun K; Huan Y; Unger PD
Arch Pathol Lab Med; 2008 Sep; 132(9):1417-22. PubMed ID: 18788852
[TBL] [Abstract][Full Text] [Related]
10. Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Sharifai N; Abro B; Chen JF; Zhao M; He H; Cao D
Hum Pathol; 2020 Aug; 102():23-32. PubMed ID: 32561332
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of P504S/p63 cocktail, prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles: a study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b.
Harvey AM; Grice B; Hamilton C; Truong LD; Ro JY; Ayala AG; Zhai QJ
Arch Pathol Lab Med; 2010 Jul; 134(7):983-8. PubMed ID: 20586625
[TBL] [Abstract][Full Text] [Related]
12. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.
Beach R; Gown AM; De Peralta-Venturina MN; Folpe AL; Yaziji H; Salles PG; Grignon DJ; Fanger GR; Amin MB
Am J Surg Pathol; 2002 Dec; 26(12):1588-96. PubMed ID: 12459625
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic adenoma: an immunohistochemical analysis using biotin-free methods.
Ortiz-Rey JA; Antón-Badiola I; Pérez-Pedrosa A; Peteiro-Cancelo Á; González-Carreró J
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):386-91. PubMed ID: 22495376
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic adenoma of the prostatic urethra: a mimicker of prostate adenocarcinoma.
Allan CH; Epstein JI
Am J Surg Pathol; 2001 Jun; 25(6):802-8. PubMed ID: 11395559
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of P504S immunohistochemistry in diagnosis and differential diagnosis of prostatic adenocarcinoma].
Chen GY; Liu LN; Zhou XG; Zhang CH; Huang SF
Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):419-23. PubMed ID: 15498210
[TBL] [Abstract][Full Text] [Related]
16. PAX2: a reliable marker for nephrogenic adenoma.
Tong GX; Melamed J; Mansukhani M; Memeo L; Hernandez O; Deng FM; Chiriboga L; Waisman J
Mod Pathol; 2006 Mar; 19(3):356-63. PubMed ID: 16400326
[TBL] [Abstract][Full Text] [Related]
17. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?
Tong GX; Weeden EM; Hamele-Bena D; Huan Y; Unger P; Memeo L; O'Toole K
Am J Surg Pathol; 2008 Sep; 32(9):1380-7. PubMed ID: 18670350
[TBL] [Abstract][Full Text] [Related]
18. Flat pattern of nephrogenic adenoma: previously unrecognized pattern unveiled using PAX2 and PAX8 immunohistochemistry.
Piña-Oviedo S; Shen SS; Truong LD; Ayala AG; Ro JY
Mod Pathol; 2013 Jun; 26(6):792-8. PubMed ID: 23328975
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry in diagnostic surgical pathology of the prostate.
Hameed O; Humphrey PA
Semin Diagn Pathol; 2005 Feb; 22(1):88-104. PubMed ID: 16512601
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic adenomas of the urethra involving the prostate gland: a report of two cases of a lesion that may be confused with prostatic adenocarcinoma.
Young RH
Mod Pathol; 1992 Nov; 5(6):617-20. PubMed ID: 1369796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
